Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · IEX Real-Time Price · USD
3.960
-1.010 (-20.32%)
At close: Jul 19, 2024, 4:00 PM
4.220
+0.260 (6.57%)
Pre-market: Jul 22, 2024, 7:14 AM EDT
Company Description
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China.
It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms.
The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.
It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.
Haoxi Health Technology Limited
Country | China |
Founded | 2018 |
IPO Date | Jan 26, 2024 |
Industry | Advertising Agencies |
Sector | Communication Services |
Employees | 32 |
CEO | Zhen Fan |
Contact Details
Address: 801/802, Tower C, Building 103, Huizhongli, Chaoyang District Beijing, F4 100101 China | |
Phone | 86-10-13311587976 |
Website | haoximedia.com |
Stock Details
Ticker Symbol | HAO |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | USD |
IPO Price | $4.00 |
CIK Code | 0001954594 |
CUSIP Number | 73936Q629 |
ISIN Number | KYG4290F1000 |
SIC Code | 7311 |
Key Executives
Name | Position |
---|---|
Zhen Fan | CEO, Director, and Chairman of the Board of Directors |
Lei Xu | Chief Operating Officer and Director Appointee |
Bo Lyu | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 18, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Jul 15, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Jun 13, 2024 | F-1 | Registration statement for certain foreign private issuers |
May 31, 2024 | 6-K | Report of foreign issuer |
May 7, 2024 | 6-K | Report of foreign issuer |
May 3, 2024 | 6-K | Report of foreign issuer |
Mar 15, 2024 | DRS | [Cover] Draft Registration Statement |
Mar 8, 2024 | 6-K | Report of foreign issuer |
Jan 30, 2024 | 6-K | Report of foreign issuer |
Jan 29, 2024 | 424B4 | Prospectus |